This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

INR

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The prothrombin time (PT) and international normalized ratio are ways of measuring of the extrinsic system in the coagulation pathway - factors II, V,VII and X

  • PT measures the extrinsic system (factor VII) as well as factors common to both the intrinsic and extrinsic systems (factors X, V, prothrombin and fibrinogen)
  • the normal clotting time is 10-14 seconds

Thromboplastin and plasma are mixed at 37 degrees C. and the time taken for a clot to form after the addition of calcium is measured; this is the prothrombin time.

The time to clot is compared to a control - this is the international normalised ratio (INR). The normal range of the INR is 0.9-1.2.

Conditions which cause a prolongation of the prothrombin time include:

  • liver disease
  • use of anticoagulants e.g. warfarin

Reference

  1. Royal Pharmaceutical Society. Liver function tests: indication and interpretation. Feb 2022 [internet publication].

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.